4,8-Dimethyl-3,7-nonadien-2-one
Common Name: |
4,8-Dimethyl-3,7-nonadien-2-one |
IUPAC Name: |
(3E)-4,8-dimethylnona-3,7-dien-2-one |
Molecular Formula: |
C11H18O |
SMILES: |
CC(=CCCC(=CC(=O)C)C)C |
Inchi: |
1S/C11H18O/c1-9(2)6-5-7-10(3)8-11(4)12/h6,8H,5,7H2,1-4H3/b10-8+ |
Inchi Key: |
QAFYGHBGWCPRCI-CSKARUKUSA-N |
Cas No: |
817-88-9 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
166.26 |
Mass (g/mol) |
166.136 |
Molar Refractivity |
54.24 |
Net Charge |
|
HBD |
|
HBA |
1 |
Rt Bonds |
4 |
Rings |
|
TPSA |
17.07 |
Hetero Atoms |
1 |
Heavy Atoms |
12 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
200.00 to 201.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.022 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.55 |
LogP |
3.268 |
iLOGP |
2.73 |
XLOGP3 |
3.25 |
WLOGP |
3.27 |
MLOGP |
2.78 |
ESOL Log S |
-2.65 |
ESOL Solubility (mg/ml) |
0.369 |
ESOL Solubility (mol/l) |
0.002 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-3.28 |
Ali Solubility (mg/ml) |
0.09 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-2.36 |
Silicos-IT Solubility (mg/ml) |
0.73 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.01 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.327 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.455 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |